Metabolomic Profiles Differentiate Scleroderma-PAH From Idiopathic PAH and Correspond With Worsened Functional Capacity
Mona Alotaibi, Junzhe Shao, Michael W. Pauciulo, William C. Nichols, Anna R. Hemnes, Atul Malhotra, Nick H. Kim, Jason X.‐J. Yuan, Timothy M. Fernandes, Kim M. Kerr, Laith Alshawabkeh, Ankit A. Desai, Andreea M. Bujor, Robert Lafyatis, Jeramie D. Watrous, Tao Long, Susan Cheng, Stephen Y. Chan, Mohit Jain
Topics & Concepts
Scleroderma (fungus)MetabolomicsChemistryEnvironmental chemistryMedicinePathologyChromatographyInoculationSystemic Sclerosis and Related DiseasesPulmonary Hypertension Research and TreatmentsInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis